Avisi is a medical devices startup investigating the use of patented nanotechnology in an ocular implant to stop blindness in glaucoma patients.
Glaucoma is the second leading cause of blindness in the world and currently has no cure.
To date, Avisi has been supported by grants and awards from: the National Science Foundation, Ben Franklin Technology Partners, the University of Pennsylvania, Wharton, The School of Engineering and Applied Science, Venture Initiation Program Accelerator (VIP-X), Penn Law's Entrepreneurship Legal Clinic, VentureWell E-Teams, and Ballard Spahr BASE.
Avisi is a proud member of Johnson & Johnson JLABS incubator, UCSF Rosenman Innovators, OC OCTANE LaunchPad, and MedTech Innovator Accelerator.
Twitter: @avisi_tech
Website: www.avisitech.com
Glaucoma is the second leading cause of blindness in the world and currently has no cure.
To date, Avisi has been supported by grants and awards from: the National Science Foundation, Ben Franklin Technology Partners, the University of Pennsylvania, Wharton, The School of Engineering and Applied Science, Venture Initiation Program Accelerator (VIP-X), Penn Law's Entrepreneurship Legal Clinic, VentureWell E-Teams, and Ballard Spahr BASE.
Avisi is a proud member of Johnson & Johnson JLABS incubator, UCSF Rosenman Innovators, OC OCTANE LaunchPad, and MedTech Innovator Accelerator.
Twitter: @avisi_tech
Website: www.avisitech.com
Location: United States, Pennsylvania, Philadelphia
Employees: 1-10
Total raised: $5.1M
Founded date: 2017
Investors 4
| Date | Name | Website |
| 05.01.2021 | Life Scien... | lifescienc... |
| - | Ben Frankl... | sep.benfra... |
| - | Good Growt... | goodgrowth... |
| - | K2X | k2x.capita... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.07.2022 | Seed | $4.1M | Life Scien... |
| 21.09.2020 | Grant | $1M | - |
Mentions in press and media 12
| Date | Title | Description |
| 27.02.2026 | Avisi Technologies Announces $10.7M Series A | REDWOOD CITY, CA, Avisi Technologies, an ophthalmic medical device company, announces the closing of $10.7M in new financing. >> Click here for more funding data on Avisi Technologies >> To export Avisi Technologies funding dat... |
| 25.02.2026 | Avisi Technologies Raises $10.7M in Series A Funding | Avisi Technologies, a Redwood City, CA-based ophthalmic medical device company, raised $10.7M in Series A funding. The round was led by MedVenture Partners, with participation from new investors Sherpa Healthcare Partners, SNBL-Gemseki, SBI... |
| 18.10.2021 | Ben Franklin Approved $2.1M in 12 Early Stage Companies | |
| 06.10.2021 | Philly’s BIPOC Entrepreneurs Get New Promises to Fund Businesses and Correct a Historic Deficit | Kimberly Wilson, a Black woman who struggled to get white doctors to take her symptoms seriously after a 2017 fibroids diagnosis, founded digital start-up HUED a year later to enable Black and Latino patients to find culturally sensitive me... |
| 18.11.2020 | RealLIST Engineers 2020: Meet 21 Influential Technologists Building a Better Philadelphia | We’ve watched a global pandemic change so much about how we navigate our personal and work lives, and a social and racial justice movement bring to light the many flaws in our existing systems. It’s upended how and where we work, and made u... |
| 27.10.2020 | Ben Franklin Approved $1.1M in 5 Early Stage Companies | |
| 21.09.2020 | Avisi Technologies eyes goal of human trials with $1M National Science Foundation grant | RealLIST Startups 2020 honoree Avisi Technologies, maker of an ocular implant to treat glaucoma, is the recent recipient of a $1 million Small Business Innovation Research Phase II grant from the National Science Foundation (NSF) — funds co... |
| 21.09.2020 | Avisi Technologies Eyes Goal of Human Trials with $1M National Science Foundation Grant | The startup, which is based out of the Pennovation Center in Grays Ferry, was founded in 2017 by Jiang and cofounder Brandon Kao. Its product, the VisiPlate, aims to treat open-angle glaucoma with an ocular implant that’s designed to remove... |
| 09.08.2019 | Penn Spinoff Takes on Glaucoma with Nanotechnology-Enabled Implant | The Philadelphia company recently landed a $225,000 federal government grant to support its work on a nanotechnology-enabled implant called the VisiPlate, which is being developed as a defense against blindness caused by glaucoma. The impla... |
| 25.07.2019 | Ben Franklin Approved 1.3M in 9 Early Stage Companies |
Show more